{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T02:35:38Z","timestamp":1789526138083,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,1,29]],"date-time":"2014-01-29T00:00:00Z","timestamp":1390953600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2334-14-45","type":"journal-article","created":{"date-parts":[[2014,1,29]],"date-time":"2014-01-29T03:01:50Z","timestamp":1390964510000},"source":"Crossref","is-referenced-by-count":49,"title":["The potential impact of expanding target age groups for polio immunization campaigns"],"prefix":"10.1186","volume":"14","author":[{"given":"Radboud J","family":"Duintjer Tebbens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominika A","family":"Kalkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven GF","family":"Wassilak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A","family":"Pallansch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen L","family":"Cochi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly M","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,1,29]]},"reference":[{"key":"3002_CR1","volume-title":"Vaccines. Fifth edition","author":"RW Sutter","year":"2008","unstructured":"Sutter RW, Kew OM, Cochi SL: Poliovirus vaccine -- live. Vaccines. Fifth edition. Edited by: Plotkin SA, Orenstein WA, Offit PA. 2008, Philadelphia: Saunders Elsevier"},{"key":"3002_CR2","first-page":"95","volume":"76","author":"World Health Organization","year":"2001","unstructured":"World Health Organization: Transmission of wild poliovirus type 2 - apparent global interruption. Wkly Epidemiol Rec. 2001, 76: 95-97.","journal-title":"Wkly Epidemiol Rec"},{"key":"3002_CR3","unstructured":"Global Polio Eradication Initiative - list of wild poliovirus by country. \n                    http:\/\/www.polioeradication.org\/Dataandmonitoring\/Poliothisweek\/Wildpolioviruslist.aspx\n                    \n                  ,"},{"key":"3002_CR4","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1111\/j.1539-6924.2012.01891.x","volume":"33","author":"KM Thompson","year":"2013","unstructured":"Thompson KM, Pallansch MA, Duintjer Tebbens RJ, Wassilak SGF, Cochi SL: Modeling population immunity to support efforts to end the transmission of live polioviruses. Risk Anal. 2013, 33: 647-663. 10.1111\/j.1539-6924.2012.01891.x.","journal-title":"Risk Anal"},{"key":"3002_CR5","volume-title":"Poliomyelitis: intensification of the global eradication initiative (resolution 65.5)","author":"World Health Assembly","year":"2012","unstructured":"World Health Assembly: Poliomyelitis: intensification of the global eradication initiative (resolution 65.5). 2012, Geneva, Switzerland: World Health Organization"},{"key":"3002_CR6","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/risa.12019","volume":"33","author":"KM Thompson","year":"2013","unstructured":"Thompson KM, Pallansch MA, Duintjer Tebbens RJ, Wassilak SG, Kim J-H, Cochi SL: Pre-eradication vaccine policy options for poliovirus infection and disease control. Risk Anal. 2013, 33: 516-543. 10.1111\/risa.12019.","journal-title":"Risk Anal"},{"key":"3002_CR7","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/S0140-6736(94)92472-4","volume":"343","author":"HF Hull","year":"1994","unstructured":"Hull HF, Ward NA, Hull BP, Milstien J, de Quadros CA: Paralytic poliomyelitis: seasoned strategies, disappearing disease. Lancet. 1994, 343: 1331-1337. 10.1016\/S0140-6736(94)92472-4.","journal-title":"Lancet"},{"key":"3002_CR8","volume-title":"Global polio eradication initiative: polio eradication and endgame strategic plan (2013\u20132018)","author":"World Health Organization","year":"2013","unstructured":"World Health Organization: Global polio eradication initiative: polio eradication and endgame strategic plan (2013\u20132018). 2013, Geneva, Switzerland: World Health Organization, Report No.: WHO\/POLIO\/13.02"},{"key":"3002_CR9","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1001\/jama.1960.03020320001001","volume":"173","author":"AB Sabin","year":"1960","unstructured":"Sabin AB, Ramos-Alvarez M, Alvarez-Amezquita J, Pelon W, Michaels RH, Spigland I, Koch MA, Barnes JM JSR: Live, orally given poliovirus vaccine: effects of rapid mass immunization on population under conditions of massive enteric infection with other viruses. JAMA. 1960, 173: 1521-1526. 10.1001\/jama.1960.03020320001001.","journal-title":"JAMA"},{"issue":"1","key":"3002_CR10","doi-asserted-by":"publisher","first-page":"S189","DOI":"10.1093\/infdis\/175.Supplement_1.S189","volume":"175","author":"JM Olive","year":"1997","unstructured":"Olive JM, Risi JB, de Quadros CA: National immunization days: experience in Latin America. J Infect Dis. 1997, 175 (1): S189-S193.","journal-title":"J Infect Dis"},{"key":"3002_CR11","first-page":"681","volume":"77","author":"P M\u00e1s Lago","year":"1999","unstructured":"M\u00e1s Lago P: Eradication of poliomyelitis in Cuba: a historical perspective. Bull World Health Organ. 1999, 77: 681-687.","journal-title":"Bull World Health Organ"},{"key":"3002_CR12","doi-asserted-by":"publisher","first-page":"S400","DOI":"10.1093\/clinids\/6.Supplement_2.S400","volume":"6","author":"JB Risi Jr","year":"1984","unstructured":"Risi JB: The control of poliomyelitis in Brazil. Rev Infect Dis. 1984, 6: S400-S403. 10.1093\/clinids\/6.Supplement_2.S400.","journal-title":"Rev Infect Dis"},{"key":"3002_CR13","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1086\/516312","volume":"26","author":"DR Prevots","year":"1998","unstructured":"Prevots DR, Atti ML C d, Sallabanda A, Diamanti E, Aylward RB, Kakariqqi E, Fiore L, Ylli A, van der Avoort HG, Sutter RW, et al: Outbreak of paralytic poliomyelitis in Albania, 1996: high attack rate among adults and apparent interruption of transmission following nationwide mass vaccination. Clin Infect Dis. 1998, 26: 419-425. 10.1086\/516312.","journal-title":"Clin Infect Dis"},{"key":"3002_CR14","first-page":"1393","volume":"59","author":"Centers for Disease Control and Prevention","year":"2010","unstructured":"Centers for Disease Control and Prevention: Outbreaks following wild poliovirus importations --- Europe, Africa, and Asia, January 2009-September 2010. Morb Mortal Wkly Rep. 2010, 59: 1393-1399.","journal-title":"Morb Mortal Wkly Rep"},{"key":"3002_CR15","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1093\/cid\/cis715","volume":"55","author":"CJ Gregory","year":"2012","unstructured":"Gregory CJ, Ndiaye S, Patel M, Hakizamana E, Wannemuehler K, Ndinga E, Chu S, Talani P, Kretsinger K: Investigation of elevated case-fatality rate in poliomyelitis outbreak in Pointe Noire, Republic of Congo, 2010. Clin Infect Dis. 2012, 55: 1299-1306. 10.1093\/cid\/cis715.","journal-title":"Clin Infect Dis"},{"key":"3002_CR16","first-page":"238","volume":"81","author":"World Health Organization","year":"2006","unstructured":"World Health Organization: Outbreak news. Poliomyelitis, Namibia. Wkly Epidemiol Rec. 2006, 81: 238-","journal-title":"Wkly Epidemiol Rec"},{"key":"3002_CR17","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/S0140-6736(94)92091-5","volume":"344","author":"P Oostvogel","year":"1994","unstructured":"Oostvogel P, van Wijngaarden J, van der Avoort HG, Mulders MN, Conyn-van Spaendonck MA, R\u00fcmke H, van Steenis G, van Loon AM: Poliomyelitis outbreak in an unvaccinated community in The Netherlands, 1992\u20133. Lancet. 1994, 344: 665-670. 10.1016\/S0140-6736(94)92091-5.","journal-title":"Lancet"},{"key":"3002_CR18","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/S0140-6736(07)60532-7","volume":"369","author":"KM Thompson","year":"2007","unstructured":"Thompson KM, Duintjer Tebbens RJ: Eradication versus control for poliomyelitis: an economic analysis. Lancet. 2007, 369: 1363-1371. 10.1016\/S0140-6736(07)60532-7.","journal-title":"Lancet"},{"key":"3002_CR19","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.vaccine.2010.10.026","volume":"29","author":"RJ Duintjer Tebbens","year":"2011","unstructured":"Duintjer Tebbens RJ, Pallansch MA, Cochi SL, Wassilak SGF, Linkins J, Sutter RW, Aylward RB, Thompson KM: Economic analysis of the global polio eradication initiative. Vaccine. 2011, 29: 334-343.","journal-title":"Vaccine"},{"key":"3002_CR20","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1111\/risa.12044","volume":"23","author":"RJ Duintjer Tebbens","year":"2013","unstructured":"Duintjer Tebbens RJ, Pallansch MA, Kalkowska DA, Wassilak SG, Cochi SL, Thompson KM: Characterizing poliovirus transmission and evolution: insights from modeling experiences with wild and vaccine-related polioviruses. Risk Anal. 2013, 23: 703-749.","journal-title":"Risk Anal"},{"key":"3002_CR21","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1111\/j.1539-6924.2012.01864.x","volume":"33","author":"RJ Duintjer Tebbens","year":"2013","unstructured":"Duintjer Tebbens RJ, Pallansch MA, Chumakov KM, Halsey NA, Hovi T, Minor PD, Modlin JF, Patriarca PA, Sutter RW, Wright PF, et al: Expert review on poliovirus immunity and transmission. Risk Anal. 2013, 33: 544-605. 10.1111\/j.1539-6924.2012.01864.x.","journal-title":"Risk Anal"},{"key":"3002_CR22","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1111\/risa.12031","volume":"33","author":"RJ Duintjer Tebbens","year":"2013","unstructured":"Duintjer Tebbens RJ, Pallansch MA, Chumakov KM, Halsey NA, Hovi T, Minor PD, Modlin JF, Patriarca PA, Sutter RW, Wright PF, et al: Review and assessment of poliovirus immunity and transmission: synthesis of knowledge gaps and identification of research needs. Risk Anal. 2013, 33: 606-646. 10.1111\/risa.12031.","journal-title":"Risk Anal"},{"key":"3002_CR23","volume-title":"Business dynamics: systems thinking and modeling for a complex world","author":"J Sterman","year":"2001","unstructured":"Sterman J: Business dynamics: systems thinking and modeling for a complex world. 2001, Boston, MA: McGraw-Hill"},{"key":"3002_CR24","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1006\/tpbi.2001.1525","volume":"60","author":"AL Lloyd","year":"2001","unstructured":"Lloyd AL: Realistic distributions of infectious periods in epidemic models: changing patterns of persistence and dynamics. Theor Popul Biol. 2001, 60: 59-71. 10.1006\/tpbi.2001.1525.","journal-title":"Theor Popul Biol"},{"key":"3002_CR25","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1111\/risa.12022","volume":"23","author":"RJ Duintjer Tebbens","year":"2013","unstructured":"Duintjer Tebbens RJ, Pallansch MA, Kim J-H, Burns CC, Kew OM, Oberste MS, Diop O, Wassilak SGF, Cochi SL, Thompson KM: Review: oral poliovirus vaccine evolution and insights relevant to modeling the risks of circulating vaccine-derived polioviruses (cVDPVs). Risk Anal. 2013, 23: 680-702.","journal-title":"Risk Anal"},{"key":"3002_CR26","unstructured":"World population prospects: the 2010 revision. \n                    http:\/\/esa.un.org\/unpd\/wpp\/Documentation\/WPP%202010%20publications.htm\n                    \n                  ,"},{"key":"3002_CR27","unstructured":"World population prospects: the 2012 revision. \n                    http:\/\/esa.un.org\/unpd\/wpp\/index.htm\n                    \n                  ,"},{"key":"3002_CR28","first-page":"846","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","unstructured":"Centers for Disease Control and Prevention: Update on vaccine-derived polioviruses--worldwide, July 2009-March 2011. MMWR Morb Mortal Wkly Rep. 2011, 60: 846-850.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"3002_CR29","volume-title":"Summary of discussions and recommendations, 16th informal consultation of the global polio laboratory network, 22\u201323 September 2010, WHO\/HQ","author":"World Health Organization","year":"2010","unstructured":"World Health Organization: Summary of discussions and recommendations, 16th informal consultation of the global polio laboratory network, 22\u201323 September 2010, WHO\/HQ. 2010, Geneva, Switzerland: World Health Organization"},{"key":"3002_CR30","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1093\/infdis\/jiq140","volume":"203","author":"SGF Wassilak","year":"2011","unstructured":"Wassilak SGF, Pate MA, Wannemuehler K, Jenks J, Burns C, Chenoweth P, Abanida EA, Adu F, Baba M, Gasasira A, et al: Outbreak of type 2 vaccine-derived poliovirus in Nigeria: emergence and widespread circulation in an underimmunized population. J Infect Dis. 2011, 203: 898-909. 10.1093\/infdis\/jiq140.","journal-title":"J Infect Dis"},{"key":"3002_CR31","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1093\/aje\/kwq320","volume":"172","author":"N Nathanson","year":"2010","unstructured":"Nathanson N, Kew OM: From emergence to eradication: the epidemiology of poliomyelitis deconstructed. Am J Epidemiol. 2010, 172: 1213-1229. 10.1093\/aje\/kwq320.","journal-title":"Am J Epidemiol"},{"key":"3002_CR32","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1111\/j.1539-6924.2006.00843.x","volume":"26","author":"KM Thompson","year":"2006","unstructured":"Thompson KM, Duintjer Tebbens RJ, Pallansch MA: Evaluation of response scenarios to potential polio outbreaks using mathematical models. Risk Anal. 2006, 26: 1541-1556. 10.1111\/j.1539-6924.2006.00843.x.","journal-title":"Risk Anal"},{"key":"3002_CR33","doi-asserted-by":"publisher","first-page":"6759","DOI":"10.1016\/j.vaccine.2012.09.023","volume":"30","author":"FJ Giwa","year":"2012","unstructured":"Giwa FJ, Olayinka AT, Ogunshola FT: Seroprevalence of poliovirus antibodies amongst children in Zaria, Northern Nigeria. Vaccine. 2012, 30: 6759-6765. 10.1016\/j.vaccine.2012.09.023.","journal-title":"Vaccine"},{"key":"3002_CR34","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1086\/427810","volume":"191","author":"F Abbink","year":"2005","unstructured":"Abbink F, Buisman AM, Doornbos G, Woldman J, Kimman TG, Conyn-van Spaendonck MAE: Poliovirus-specific memory immunity in seronegative elderly people does not protect against virus excretion. J Infect Dis. 2005, 191: 990-999. 10.1086\/427810.","journal-title":"J Infect Dis"},{"key":"3002_CR35","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/oxfordjournals.aje.a121058","volume":"90","author":"PW Glezen","year":"1969","unstructured":"Glezen PW, McCollough RH, Lamb GA, Chin TDY: Quantitative relationship of preexisting homotypic antibodies to excretion of poliovirus types 1, 2, and 3 following the feeding of trivalent attenuated poliovirus vaccine. Am J Epidemiol. 1969, 90: 146-156.","journal-title":"Am J Epidemiol"},{"key":"3002_CR36","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/oxfordjournals.aje.a120578","volume":"83","author":"WP Glezen","year":"1966","unstructured":"Glezen WP, Lamb GA, Belden EA, Chin TD: Quantitative relationship of preexisting homotypic antibodies to the excretion of attenuated poliovirus type 1. Am J Epidemiol. 1966, 83: 224-237.","journal-title":"Am J Epidemiol"},{"key":"3002_CR37","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1017\/S0022172400055133","volume":"76","author":"JWG Smith","year":"1976","unstructured":"Smith JWG, Lee JA, Fletcher WB, Yetts R, Magrath DI, Perkins FT: The response to oral poliovaccine in persons aged 16\u201318\u00a0years. Journal of Hygiene Cambridge. 1976, 76: 235-247. 10.1017\/S0022172400055133.","journal-title":"Journal of Hygiene Cambridge"},{"key":"3002_CR38","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1055\/s-0028-1112269","volume":"88","author":"R Siegert","year":"1963","unstructured":"Siegert R, Enders-Ruckle G, Oehme J, Waller D: Der einflu\u00df der pr\u00e4vakzinalen immunit\u00e4t auf die virusausscheidung und antik\u00f6rperproduktion nach polio-schluckimpfung mit Typ I (Sabin) [the effect of prevaccinal immunity on virus excretion and antibody production after polio immunization with type I (Sabin)]. Deutsche medizinische Wochenschrift. 1963, 88: 1586-1594. 10.1055\/s-0028-1112269.","journal-title":"Deutsche medizinische Wochenschrift"},{"key":"3002_CR39","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1093\/aje\/kws378","volume":"177","author":"BT Mayer","year":"2013","unstructured":"Mayer BT, Eisenberg JN, Henry CJ, Gomes MG, Ionides EL, Koopman JS: Successes and shortcomings of polio eradication: a transmission modeling analysis. Am J Epidemiol. 2013, 177: 1236-1245. 10.1093\/aje\/kws378.","journal-title":"Am J Epidemiol"},{"key":"3002_CR40","volume-title":"J Infect Dis","author":"DA Kalkowska","year":"2014","unstructured":"Kalkowska DA, Duintjer Tebbens RJ, Thompson KM: Modeling strategies to increase population immunity and prevent poliovirus transmission in the high-risk area of northwest Nigeria. J Infect Dis. 2014, (In press). doi:10.1093\/infdis\/jit834"},{"key":"3002_CR41","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1586\/erv.11.195","volume":"11","author":"KM Thompson","year":"2012","unstructured":"Thompson KM, Duintjer Tebbens RJ: Current polio global eradication and control policy options: perspectives from modeling and prerequisites for OPV cessation. Expert Reviews of Vaccines. 2012, 11: 449-459. 10.1586\/erv.11.195.","journal-title":"Expert Reviews of Vaccines"},{"key":"3002_CR42","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1111\/risa.12032","volume":"33","author":"SA Lowther","year":"2013","unstructured":"Lowther SA, Roesel S, O\u2019Connor P, Landaverde M, Oblapenko G, Deshevoi S, Ajay G, Buff A, Safwat H, Salla M, et al: World Health Organization regional assessments of the risks of poliovirus outbreaks. Risk Anal. 2013, 33: 664-679. 10.1111\/risa.12032.","journal-title":"Risk Anal"},{"key":"3002_CR43","volume-title":"J Infect Dis","author":"KM Thompson","year":"2014","unstructured":"Thompson KM, Duintjer Tebbens RJ: Modeling the dynamics of oral poliovirus vaccine cessation. J Infect Dis. 2014, (In press). doi:10.1093\/infdis\/jit845"},{"key":"3002_CR44","doi-asserted-by":"publisher","first-page":"3760","DOI":"10.1016\/j.vaccine.2011.03.034","volume":"29","author":"S Kidd","year":"2011","unstructured":"Kidd S, Goodson JL, Aramburu J, Morais A, Gaye A, Wannemuehler K, Buffington J, Gerber S, Wassilak S, Uzicanin A: Poliomyelitis outbreaks in Angola genetically linked to India: risk factors and implications for prevention of outbreaks due to wild poliovirus importations. Vaccine. 2011, 29: 3760-3766. 10.1016\/j.vaccine.2011.03.034.","journal-title":"Vaccine"},{"key":"3002_CR45","first-page":"484","volume":"62","author":"Centers for Disease C, Prevention","year":"2013","unstructured":"Centers for Disease C, Prevention: Notes from the field: outbreak of poliomyelitis--Somalia and Kenya, May 2013. Morb Mortal Wkly Rep. 2013, 62: 484-","journal-title":"Morb Mortal Wkly Rep"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-14-45.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-14-45\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-14-45","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-14-45.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T04:58:39Z","timestamp":1548219519000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-14-45"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,29]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["3002"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-14-45","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,29]]},"article-number":"45"}}